Skip to main content
. 2023 Aug 19;17:11795565231192965. doi: 10.1177/11795565231192965

Table 1.

Clinical characteristics of the study population, n = 20.

Variable (n = 20, unless otherwise noted)
Age at RAM cannula NIV initiation (months), median (IQR) 5.8 (2.4-9.9)
Gender, n (%)
 Male 6 (30)
 Female 14 (70)
Diagnoses, n (%) a
 Bronchopulmonary dysplasia 4 (20)
 Restrictive lung disease 5 (25)
 Genetic disorders 13 (65)
Indications for NIV use, n (%) b
 Sleep-related hypoventilation 3 (15)
 Restrictive lung disease 5 (25)
 Obstructive sleep apnea 9 (45)
 Chronic respiratory failure with hypercapnia 10 (50)
Polysomnography results, n = 13
 Central sleep apnea, n (%) 1 (7.7)
 Obstructive sleep apnea, n (%) 12 (92.3)
 Sleep-related hypoxemia, n (%) 6 (46.2)
 Sleep-related hypoventilation, n (%) 7 (53.8)
 Total AHI (events per hour), median (IQR) 16.5 (7.3-24.6)
 Obstructive AHI (events per hour), median (IQR) 10.2 (5.5-23.0)
 Central AHI (events per hour), median (IQR) 1.35 (0.5-3.5)

Abbreviations: AHI, apnea-hypopnea index; IQR, interquartile range; NIV, noninvasive ventilation.

a

Genetic disorders included Trisomy 18 (n = 6), Trisomy 21 (n = 2), Prader-Willi syndrome (n = 1), partial trisomy 2q (n = 1), Crouzon syndrome (n = 1), and osteogenesis imperfecta (n = 2). Restrictive lung diseases included prune belly syndrome (n = 1), osteogenesis imperfecta (n = 2), arthrogryposis (n = 1), and thoracic insufficiency (n = 1). Two patients had Trisomy 21 and bronchopulmonary dysplasia. Two patients had osteogenesis imperfecta and restrictive lung disease.

b

Six patients had more than 1 indication for NIV use.